As businesses have struggled and shuttered across the country, select industries have emerged as survivors. Cannabis is a prime example.

POSaBIT (CSE:PBIT), offering a proprietary debit card processing solution for marijuana dispensaries across the country, has thrived. Their safe, relatively contactless debit card transaction has allowed consumers to forgo handling cash. Perhaps more importantly, POSaBIT’s mobile capabilities have allowed for safe, efficient curbside pickup and delivery purchases.


Not only has debit card processing capabilities pleased consumers, it’s been a boon to the dispensaries themselves. Average card purchases across all of POSaBIT’s stores have soared to over $90 compared to an average purchase of just over $40 for cash tickets.

“Currently we are processing hundreds of curbside debit transactions a day via POSaBIT,” said Brendon Greney, Director of Operations at Organic Alternatives. “This is both a great service to our customers and our staff, as it adds an increased layer of social distancing and minimal interaction. Curbside pickup via POSaBIT has become an integral part of our day to day operations. It has presented several ancillary benefits as well, such as a sharp increase in budtender tips and shorter ticket times.”

“We are living in a different world than we were a few months ago,” said Ryan Hamlin, CEO and co-founder of POSaBIT. “Consumers expect the stores they patronize to care about their safety. Consumers, in general, have always wanted the ability to pay for goods with a card. Add these two facts together, and what we offer at POSaBIT, quite simply, represents the new normal.”

POSaBIT’s proprietary debit payment solution allows consumers to easily and efficiently purchase their cannabis products with debit cards. They offer this solution integrated into their best of class point of sale solution as well as in stand-alone form to dispensaries that want to take advantage of the use of debit cards but still want to keep their current Point of Sale. POSaBIT introduced their point of sale in 2018 to widespread acclaim and now have hundreds of merchants using either their point of sale or stand alone payments solution.

ABOUT POSABIT
POSaBIT (CSE: PBIT) is a financial technology company that delivers unique and innovative blockchain-enabled payment processing and point-of-sale systems for cash-only businesses. POSaBIT specializes in resolving pain points for complex, high-risk, emerging industries like cannabis with an all-in-one solution that is compliant, user-friendly and utilizes top-of-the-line hardware. POSaBIT’s unique solution provides a safe and transparent environment for merchants while creating a better overall experience for the consumer. For additional information, visit: www.posabit.com.

Source

Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, is pleased to announce the appointment of Mr. Al Reese, Jr., to its Board of Directors

Mr. Reese has over 40 years experience in public and private businesses including as CFO of a formerly Nasdaq-listed energy company where he arranged finance transactions totaling over $10 billion dollars during his 20-year tenure. Mr. Reese was a Director and Chairman of the Audit Committee of a community bank in Texas for ten years until such time as it was acquired by a larger banking group in 2018.

Keep reading... Show less

Mexico looks to be closer than ever to cannabis reform, with the country releasing its regulation plans to make the drug legal in medical settings.

Meanwhile, despite the financial hardships seen recently in the Canadian cannabis market, CEOs in the country are still receiving top dollar, as per a new study.

Keep reading... Show less

Not for Distribution to United States Newswire Services or for Dissemination in the United States

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today the pricing of its previously announced best efforts overnight marketed offering (the “Offering”) of subordinate voting shares (the “Offered Securities”) of the Company at a price of C$16.00 per share for a total gross proceeds of approximately US$125 Million. The issue price represents a 3.3% discount to the last close of the Company’s subordinate voting shares traded on the Canadian Securities Exchange as of January 14, 2021. 100% of the Offering is expected to be purchased by a total of seven new and existing institutional investors, including current shareholder, Wasatch Global Investors.

Keep reading... Show less

Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from leaders at: Tilray, Inc. (NASDAQ: TLRY), Icanic Brands (OTC: ICNAF) (CSE: ICAN) Red Light Holland (OTC: TRUFF) (CSE: TRIP) and Aphria, Inc. (NASDAQ: APHA).

Investors are cheering new and expected legislation which is opening new market opportunities for both cannabis and psychedelics globally. Innovation in premium branding, growing technologies, manufacturing, with operational execution are key, in the drive towards profitability. Wall Street Reporter highlights the latest comments from industry thought leaders in cannabis and psychedelics:

Keep reading... Show less

Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the “Company”) today announced the closing of its previously announced underwritten public offering (the “Offering”) of 1,828,571 units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock at a public offering price of $5.25 per unit (all prices in US$). The warrants have an exercise price of $6.58 per share, are immediately exercisable and will expire five years following the date of issuance. In connection with the Offering, the underwriter exercised in full its option to purchase an additional 274,285 shares of common stock and additional warrants to purchase 274,285 shares of common stock. The gross proceeds from the Offering were approximately $11.04 million, before deducting underwriting discounts and estimated offering expenses. No securities were offered or sold in Canada, including through the CSE or any other trading market in Canada

H.C. Wainwright & Co. (“Wainwright”) acted as the sole book-running manager for the Offering and is a non-related party to the Company.

Keep reading... Show less